Volume 17 -                   Qom Univ Med Sci J 2023, 17 - : 152-166 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sami Deli O, Khezri S, Abtahi Froushani S M. Comparing the Effects of Theobromine and Prednisolone on Disease Severity and Inflammatory Markers in Female Rats With Ulcerative Colitis. Qom Univ Med Sci J 2023; 17 : 1927.3
URL: http://journal.muq.ac.ir/article-1-3247-en.html
Comparing the Effects of Theobromine and Prednisolone on Disease Severity and Inflammatory Markers in Female Rats With Ulcerative Colitis
Omid Sami Deli1 , Shiva Khezri * 2, Seyed Meysam Abtahi Froushani3
1- Department of Biology, Faculty of Science, Urmia University, Urmia, Iran.
2- Department of Biology, Faculty of Science, Urmia University, Urmia, Iran. , skhezri72@gmail.com
3- Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
Abstract:   (1858 Views)
Background and Objectives: Ulcerative colitis (UC) is a chronic inflammatory disease of the large intestine and rectum that is associated with symptoms such as rectal bleeding, diarrhea, and sometimes abdominal pain. Theobromine is an alkaloid which is found in coffee beans, cocoa beans, and tea leaves. This study aims to evaluate the effectiveness of theobromine, compared to prednisolone, in treating inflammation in female rats with UC.
Methods: In this experimental study on 24 female Wistar rats, after induction of UC with injection of acetic acid 4%, rats were divided into four groups: Control, UC, UC+prednisolone (10 mg/kg) and UC+theobromine (100 mg/kg). All rats were evaluated daily for changes in body weight, the existence of blood in the stool, and stool consistency. After 10 days, the rats were killed and were examined in terms of macroscopic lesions and the production of biochemical markers in the intestinal tissue including myeloperoxidase (MPO), nitric oxide (NO), malondialdehyde (MDA), total antioxidant capacity (TAC), and protein content. Analysis of biochemical data was performed by one-way ANOVA, and the data related to disease severity were analyzed by the Friedman test.
Results: The results for the weight factor indicated that the UC group had severe weight loss, and in the groups treated with theobromine and prednisolone, the weight of rats gradually increased. The disease severity increased in the UC group but decreased in the treated groups. Macroscopic examination showed that the tissue wound and bleeding in the treated groups were much lower than in the UC group and were almost similar to those in the control group. In the UC group, the levels of MPO, NO, and MDA increased significantly compared to the control group (P<0.05), and treatment with theobromine and prednisolone significantly reduced the level of these markers. In contrast, the TAC and protein content decreased in the UC group, compared to the control group, while there was a significant increase in the treated groups compared to the UC group.
Conclusion: Treatment with theobromine and prednisolone can reduce tissue wounds and bleeding, as well as the MPO, NO, and MDA levels in female rats with UC.
Article number: 1927.3
Keywords: Ulcerative colitis, Theobromine, Prednisolone, Acetic acid, Rats
Full-Text [PDF 5394 kb]   (398 Downloads) |   |   Full-Text (HTML)  (403 Views)  
Type of Study: Original Article | Subject: فیزیولوژی
Received: 2021/09/8 | Accepted: 2021/12/14 | Published: 2021/12/31
References
1. Ashihara H. Plant biochemistry: Trigonelline biosynthesis in Coffea arabica and Coffea canephora. Coffee Health Dis Prev. 2015; 19-28. [DOI:10.1016/B978-0-12-409517-5.00003-6] [DOI:10.1016/B978-0-12-409517-5.00003-6]
2. Barbalho SM, Bosso H, Salzedas-Pescinini LM, de Alvares Goulart R. Green tea: A possibility in the therapeutic approach of inflammatory bowel diseases? Green tea and inflammatory bowel diseases. Complement Ther Med. 2019; 43:148-53. [DOI:10.1016/j.ctim.2019.01.015] [PMID] [DOI:10.1016/j.ctim.2019.01.015]
3. Arnaud M. Products of metabolism of caffeine. In: Dews PB, editor. Caffeine. Berlin: Springer; 1984. [DOI:10.1007/978-3-642-69823-1_1] [DOI:10.1007/978-3-642-69823-1_1]
4. Azam S, Hadi N, Khan NU, Hadi SM. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med Sci Monit. 2003; 9(9):BR325-30. [PMID]
5. Motegi T, Katayama M, Uzuka Y, Okamura Y. Evaluation of anticancer effects and enhanced doxorubicin cytotoxicity of xanthine derivatives using canine hemangiosarcoma cell lines. Res Vet Sci. 2013; 95(2):600-5. [DOI:10.1016/j.rvsc.2013.06.011] [PMID] [DOI:10.1016/j.rvsc.2013.06.011]
6. Suravajhala R, Poddar R, Nallapeta S, Ullah S. Xanthine derivatives: A molecular modeling perspective. In: Kavi Kishor PB, Bandopadhyay R, Suravajhala P, editors. Agricultural bioinformatics. Berlin: Springer; 2014. [DOI:10.1007/978-81-322-1880-7_17] [DOI:10.1007/978-81-322-1880-7_17]
7. Georgieva M, Kondeva-Burdina M, Mitkov J, Tzankova V, Momekov G, Zlatkov A. Determination of the antiproliferative activity of new theobromine derivatives and evaluation of their in vitro hepatotoxic effects. Anticancer Agents Med Chem. 2016; 16(7):925-32. [DOI:10.2174/1871520616666151116122633] [PMID] [DOI:10.2174/1871520616666151116122633]
8. Daly JW. Caffeine analogs: Biomedical impact. Cell Mol Life Sci. 2007; 64(16):2153-69. [DOI:10.1007/s00018-007-7051-9] [PMID] [DOI:10.1007/s00018-007-7051-9]
9. Duan L, Yang J, Slaughter MM. Caffeine inhibition of ionotropic glycine receptors. J Physiol. 2009; 587(Pt 16):4063-75. [DOI:10.1113/jphysiol.2009.174797] [PMID] [PMCID] [DOI:10.1113/jphysiol.2009.174797]
10. Fredholm BB, Bättig K, Holmén J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999; 51(1):83-133. [link]
11. Head CA, Jurenka JS. Inflammatory bowel disease part I: Ulcerative colitis-pathophysiology and conventional and alternative treatment options. Alternat Med Rev. 2003; 8(3):247-83. [link]
12. Gassull MA. Review article: The role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 20(Suppl 4):79-83. [DOI:10.1111/j.1365-2036.2004.02050.x] [PMID] [DOI:10.1111/j.1365-2036.2004.02050.x]
13. Hindryckx P, Jairath V, D'Haens G. Acute severe ulcerative colitis: From pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol. 2016; 13(11):654-64. [DOI:10.1038/nrgastro.2016.116] [PMID] [DOI:10.1038/nrgastro.2016.116]
14. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004; 50(2):81-92. [DOI:10.1016/j.vascn.2003.12.002] [PMID] [DOI:10.1016/j.vascn.2003.12.002]
15. Kumar V, Abbas AK, Aster JC. Robbins and cotran pathologic basis of disease, professional edition e-book. Amsterdam: Elsevier Health Sciences; 2020. [Link]
16. Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults (update): American college of gastroenterology, practice parameters committee. Am J Gastroenterol. 2004; 99(7):1371-85. [DOI:10.1111/j.1572-0241.2004.40036.x] [PMID] [DOI:10.1111/j.1572-0241.2004.40036.x]
17. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut. 2006; 55(6):749-53.[DOI:10.1136/gut.2005.082909] [PMID] [PMCID] [DOI:10.1136/gut.2005.082909]
18. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut. 1998; 43(1):29-32. [DOI:10.1136/gut.43.1.29] [PMID] [PMCID] [DOI:10.1136/gut.43.1.29]
19. Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, et al. Measuring myeloperoxidase activity in biological samples. Plos One. 2013; 8(7):e67976. [DOI:10.1371/journal.pone.0067976] [PMID] [PMCID] [DOI:10.1371/journal.pone.0067976]
20. Froushani SM, Galeh HE. New insight into the immunomodulatory mechanisms of Tretinoin in NMRI mice. Iran J Basic Med Sci. 2014; 17(9):632-7. [PMID] [PMCID]
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8. [DOI:10.1016/0003-2697(79)90738-3] [PMID] [DOI:10.1016/0003-2697(79)90738-3]
22. Barnes PJ. The problem of cough and development of novel antitussives. Pulm Pharmacol Ther. 2007; 20(4):416-22. [DOI:10.1016/j.pupt.2006.11.001] [PMID] [DOI:10.1016/j.pupt.2006.11.001]
23. Lee HJ, Lee KW, Kang KS, Kim DY, Park HH, Lee MJ, et al. Theobromine with an anti-carcinogenic activity [Internet]. 2004 [Updated 2023 August6 27]. Available from: [Link] [DOI:10.1248/bpb.27.1883]
24. Iaia N, Rossin D, Sottero B, Venezia I, Poli G, Biasi F. Efficacy of theobromine in preventing intestinal CaCo-2 cell damage induced by oxysterols. Arch Biochem Biophys. 2020; 694:108591. [DOI:10.1016/j.abb.2020.108591] [PMID] [DOI:10.1016/j.abb.2020.108591]
25. Halliwell B. Antioxidant characterization. Methodology and mechanism. Biochem Pharmacol. 1995; 49(10):1341-8. [DOI:10.1016/0006-2952(95)00088-H] [PMID] [DOI:10.1016/0006-2952(95)00088-H]
26. Macaigne G, Lahmek P, Locher C, Lesgourgues B, Costes L, Nicolas MP, et al. Microscopic colitis or functional bowel disease with diarrhea: A French prospective multicenter study. Am J Gastroenterol. 2014; 109(9):1461-70. [DOI:10.1038/ajg.2014.182] [PMID] [DOI:10.1038/ajg.2014.182]
27. Ansley DM, Wang B. Oxidative stress and myocardial injury in the diabetic heart. J Pathol. 2013; 229(2):232-41. [DOI:10.1002/path.4113] [PMID] [PMCID] [DOI:10.1002/path.4113]
28. Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res. 2008; 638(1-2):98-102. [DOI:10.1016/j.mrfmmm.2007.09.002] [PMID] [DOI:10.1016/j.mrfmmm.2007.09.002]
29. Salamatian M, Mohammadi V, Abtahi Froushani SM. [Ameliorative effects of aqueous cinnamon extract on ulcerative colitis in rats (Persian)]. Physiol Pharmacol. 2019; 23(2):140-9. [Link]
30. Esmaeilnejad B, Abtahi Froushani SM, Tehrani AA, Esmaeili Gouvarchin Ghaleh H, Moshrefzadeh F. [The effects of fasciola hepatica on acetic acid induced ulcerative colitis in rat model (Persian)]. J Fasa Univ Med Sci. 2018; 8(4):1136-45. [Link]
31. Varshosaz J, Minaiyan M, Mollanoori E. [Anti-inflammatory effects of ketotifen in acetic acid-induced ulcerative colitis in rats (Persian)]. J Isfahan Med Sch. 2013; 31(226):138-49. [Link]
32. Tahmasebi P, Abtahi Froushani SM, Afzale Ahangaran N. Thymol has beneficial effects on the experimental model of ulcerative colitis. Avicenna J Phytomed. 2019; 9(6):538-50.[DOI:10.22038/AJP.2019.13383] [PMID] [PMCID]
33. Abtahi Froushani SM, Abbasi A. [Conditioned medium of mesenchymal stem cells pulsed with theobromine can instruct anti-inflammatory neutrophils (Persian)]. Zahedan J Res Med Sci. 2020; 22(2):e86967. [DOI:10.5812/zjrms.86967] [DOI:10.5812/zjrms.86967]
34. Abtahi Froushani SM, Mashouri S. [The beneficial effects of hypiran in Ameliorating Rat Model of Ulcerative Colitis (Persian)]. Zahedan J Res Med Sci. 2018; 20(1):e58919. [DOI:10.5812/zjrms.58919] [DOI:10.5812/zjrms.58919]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Qom University of Medical Sciences Journal

Designed & Developed by : Yektaweb